Comparison of WNK4 and WNK1 kinase and inhibiting activities

Zhaohong Wang1, Chao-Ling Yang, David H Ellison

  • 1Division of Nephrology and Hypertension, Department of Medicine, Oregon Health and Science University, Portland, OR 97239, USA.

Insights

WNK4 requires activation for kinase activity and can inhibit WNK1. This research explores WNK kinase regulation in ion transport and hypertension.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Physiology

Background:

  • WNK kinases (WNK1, WNK4) are serine/threonine protein kinases implicated in familial hyperkalemic hypertension.
  • Mutations in WNK1 and WNK4 disrupt ion transport, affecting epithelial function.
  • WNK4 regulates the Na-Cl cotransporter and ROMK potassium channel by controlling their plasma membrane localization.

Purpose of the Study:

  • To investigate the in vitro kinase activity of WNK1 and WNK4.
  • To identify regulatory domains within WNK1 and WNK4.
  • To understand the inhibitory interactions between WNK4 and WNK1.

Main Methods:

  • In vitro kinase assays using glutathione S-transferase (GST) fusion proteins of WNK1 and WNK4 domains.
  • Expression and analysis of WNK constructs in HEK 293 cells.
  • Assessment of WNK4's inhibitory effect on WNK1 kinase activity.

Main Results:

  • The WNK1 kinase domain exhibited autophosphorylation and substrate phosphorylation.
  • A longer WNK1 construct with an autoinhibitory domain lacked kinase activity.
  • WNK4 kinase domain constructs showed no detectable kinase activity in vitro or in cells.
  • WNK4 segments homologous to WNK1's autoinhibitory domain inhibited WNK1 kinase activity, with WNK4 (444-518) being more potent.

Conclusions:

  • WNK4 requires activation by unknown factors to become catalytically active.
  • WNK4 possesses an inhibitory domain capable of suppressing WNK1 kinase activity.
  • These findings provide insights into the complex regulation of WNK kinases and their role in ion homeostasis and hypertension.

Related Concept Videos

Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.